Literature DB >> 4067642

Validation of left ventricular volume measurements by radionuclide angiography.

M S Verani, J Gaeta, A D LeBlanc, L R Poliner, L Phillips, J L Lacy, J I Thornby, R Roberts.   

Abstract

A nongeometric, attenuation-corrected technique to quantitate left ventricular volumes using equilibrium radionuclide angiography was validated in vitro and in vivo. In vitro experiments were performed to derive a linear attenuation coefficient, which was then employed in the volume determinations using balloons in a water bath. Good in vitro correlation was found between radionuclide and actual volumes (r = 0.99, p less than 0.0001), over a wide range (5 to 400 ml). In vivo validation was done by comparing the nuclear technique to contrast angiography in 29 patients: Good correlations were found for end-diastolic volume (r = 0.98), end-systolic volume (r = 0.95), stroke volume (r = 0.96), and ejection fraction (r = 0.85). When the conventional linear attenuation coefficient was used, the radionuclide technique consistently overestimated volumes in vitro and in vivo. Although high intraobserver and interobserver correlation coefficients were found (r from 0.88 to 0.93), significant individual variability existed, particularly in the interobserver data. Our data provide unique validation of radionuclide volume determinations, using an experimentally determined attenuation coefficient, which results in improved accuracy.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4067642

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  12 in total

1.  A simple single slice method for measurement of left and right ventricular enlargement by electron beam tomography.

Authors:  S Mao; M J Budoff; R J Oudiz; H Bakhsheshi; S Wang; B H Brundage
Journal:  Int J Card Imaging       Date:  2000-10

2.  Reliability of first-pass radionuclide determination of cardiac output in the upright position at rest and during exercise.

Authors:  H Kelbaek; T Gjørup; K Hvid-Jacobsen; K Skagen; O Munck; J Godtfredsen; L Heslet
Journal:  Eur J Nucl Med       Date:  1992

Review 3.  Role of nuclear cardiac imaging in myocardial infarction: postinfarction risk stratification.

Authors:  John J Mahmarian; Girish Dwivedi; Tultul Lahiri
Journal:  J Nucl Cardiol       Date:  2004 Mar-Apr       Impact factor: 5.952

Review 4.  Choosing a nuclear medicine study for cardiovascular applications.

Authors:  W H Moore
Journal:  Tex Heart Inst J       Date:  1996

Review 5.  Ninth annual Mario S. Verani memorial lecture : testing our tests: the evidence bar is rising. Regulatory considerations in the development of cardiac imaging agents.

Authors:  James E Udelson
Journal:  J Nucl Cardiol       Date:  2011-08       Impact factor: 5.952

6.  The reliability of measuring left ventricular ejection fraction by radionuclide cardiography: evaluation by the method of variance components.

Authors:  P F Høilund-Carlsen; S L Lauritzen; J Marving; S Rasmussen; B Hesse; K Folke; J Godtfredsen; B Chraemmer-Jørgensen; N Gadsbøll; H Dige-Petersen
Journal:  Br Heart J       Date:  1988-06

7.  Should all patients undergo cardiac catheterization after a myocardial infarction?

Authors:  M S Verani
Journal:  J Nucl Cardiol       Date:  1994 Sep-Oct       Impact factor: 5.952

8.  Comparison of interstudy reproducibility of equilibrium electrocardiography-gated SPECT radionuclide angiography versus planar radionuclide angiography for the quantification of global left ventricular function.

Authors:  Doumit Daou; Carlos Coaguila; Abdel Benada
Journal:  J Nucl Cardiol       Date:  2006 Mar-Apr       Impact factor: 5.952

9.  Does impedance cardiography reliably estimate left ventricular ejection fraction?

Authors:  N J van der Meer; M W Oomen; A Vonk Noordegraaf; R J Pijpers; M A Plaizier; P M de Vries
Journal:  J Clin Monit       Date:  1996-01

Review 10.  Quantitative radionuclide angiocardiography.

Authors:  J Grégoire; J A Parker; B L Holman
Journal:  Cardiovasc Intervent Radiol       Date:  1987       Impact factor: 2.740

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.